Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Capital Expenditures (2016 - 2025)

Eastman Chemical (EMN) has disclosed Capital Expenditures for 17 consecutive years, with $137.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Capital Expenditures rose 14.17% year-over-year to $137.0 million, compared with a TTM value of $613.0 million through Sep 2025, up 2.34%, and an annual FY2024 reading of $599.0 million, down 27.66% over the prior year.
  • Capital Expenditures was $137.0 million for Q3 2025 at Eastman Chemical, down from $150.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $303.0 million in Q3 2021 and bottomed at -$292.0 million in Q4 2021.
  • Average Capital Expenditures over 5 years is $99.8 million, with a median of $137.0 million recorded in 2025.
  • The sharpest move saw Capital Expenditures crashed 378.1% in 2021, then skyrocketed 7766.67% in 2023.
  • Year by year, Capital Expenditures stood at -$292.0 million in 2021, then surged by 101.03% to $3.0 million in 2022, then soared by 5866.67% to $179.0 million in 2023, then changed by 0.0% to $179.0 million in 2024, then decreased by 23.46% to $137.0 million in 2025.
  • Business Quant data shows Capital Expenditures for EMN at $137.0 million in Q3 2025, $150.0 million in Q2 2025, and $147.0 million in Q1 2025.